Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
10:32am, Tuesday, 17'th Jan 2023
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Pick Either Johnson & Johnson Stock Or Its Peer – Both May Offer Similar Returns
07:00am, Tuesday, 17'th Jan 2023
We believe that pharmaceutical giants Johnson & Johnson stock (NYSE: JNJ) and Merck stock (NYSE: MRK) will likely offer similar returns over the next three years.
2 Dow Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
05:06am, Tuesday, 17'th Jan 2023
Among the Dow Jones Industrial Average's 30 components, there are two jaw-dropping deals and one overachiever worth avoiding.
The 5 Best-Performing Dividend Stocks In 2023?
07:45am, Saturday, 14'th Jan 2023
With economic uncertainty ahead, many investors will be looking for the best dividend investment opportunities for 2023. Here are the top performers so far.
J&J slashes production of its unpopular COVID-19 shot
01:50pm, Friday, 13'th Jan 2023
A partnership with rival Merck & Co. to help make the shots, forged at the urging of the U.S. government, hasn't lived up to expectations. The companies are now engaged in arbitration.
3 Dividend Growth Stocks To Buy In January 2023
06:00pm, Wednesday, 11'th Jan 2023
Dividend growth stocks can contribute significantly to increasing your additional income in the form of dividends year over year. In this article I will present 3 companies that I currently consider t
3 Dividend King Stocks That Can Make You Money in Your Sleep
02:00pm, Wednesday, 11'th Jan 2023
These players offer you passive income and a whole lot more.
Johnson & Johnson Is A Better Dividend Stock Than Roche, Despite A 20% Lower Yield
11:45am, Wednesday, 11'th Jan 2023
In the first part of this article, I provide easy-to-digest overviews of U.S. pharmaceutical and medical technology giant Johnson & Johnson and Swiss biologics and diagnostics king Roche Holding AG. I
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
11:20am, Wednesday, 11'th Jan 2023 Zacks Investment Research
Sector ETF report for IYH
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
11:20am, Wednesday, 11'th Jan 2023 Zacks Investment Research
Sector ETF report for XLV
Should Vanguard Mega Cap Value ETF (MGV) Be on Your Investing Radar?
11:20am, Wednesday, 11'th Jan 2023 Zacks Investment Research
Style Box ETF report for MGV
Fundsmith Equity Fund 2022 Annual Letter To Shareholders
08:15am, Wednesday, 11'th Jan 2023 Seeking Alpha
Consistently high ROC and source of growth are signs we look for when seeking companies to invest in. So how did our cos. fare in that respect in 2022? Find out.
Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know
10:45pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
In the latest trading session, Johnson & Johnson (JNJ) closed at $175.16, marking a -0.24% move from the previous day.
Emergent (EBS) to Start Restructuring Plan, Lays Off 5% Workforce
05:06pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
Once this restructuring activity is completed, Emergent BioSolutions (EBS) expects to result in annualized savings of over $60 million. It also slightly raised its total revenue guidance for 2022.
Best Stocks To Buy In 2023? 2 Health Care Stocks To Know
10:59am, Tuesday, 10'th Jan 2023
Are these the best health care stocks to buy in 2023?
